Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain microRNAs found in normal cells can effectively suppress various cancers.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Higher DHT in male baldness may protect against prostate cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Clinicians can use vibe coding to easily engage in machine learning research without needing to know Python.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Higher cholesterol levels increase aggressive prostate cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Suppressing certain hormones might help prevent prostate cancer.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.